Cytodyn Inc (CYDY)

[LifeLongLearner]

Misiu143

The FDA has clearly been playing this dosage game with HIV, CD12, and cancer. Even IF there was adverse side effects to Leronlimab, these patients are dying. Without Leronlimab these patients will experience the worst SAE possible - death.

When you contrast the dosage restrictions on Leronlimab (with no side effects) with the pump patients with as much Remdesivir as you want (with lots of side effects), you are just left wondering how can this be?

To say that Leronlimab has failed its trials is like saying Babe Ruth was a failure because you have redefined a home run as a ball hit over 1,000 feet. If you play with the rules enough, anything can be defined as a failure.